JAMA Otolaryngology–Head & Neck Surgery· 2026Q1
Newborn Hearing Screening in the Otoferlin Gene Therapy Era
- 0citations
- Q1SCImago
- 2026year
Short summary
This Viewpoint advocates for updating newborn hearing screening protocols to incorporate automated auditory brainstem response (AABR) testing for otoferlin (OTOF) gene therapy candidacy.
AI-generated from the title and abstract; the full text is not read.
Abstract
The Viewpoint advocates for updates to newborn hearing screening recommendations to include automated auditory brainstem response testing to determine candidacy for otoferlin ( OTOF ) gene therapy.
The authors' abstract, as published at the source. JAMA Otolaryngology–Head & Neck Surgery, 2026 · DOI ↗
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Sensory Systems
Sensory SystemsNeuroscience